中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
8期
664-666
,共3页
王淑梅%孙路路%曾蔚欣%章国良
王淑梅%孫路路%曾蔚訢%章國良
왕숙매%손로로%증위흔%장국량
急性淋巴细胞白血病%细胞色素P4501A2%甲氨蝶呤%血清浓度
急性淋巴細胞白血病%細胞色素P4501A2%甲氨蝶呤%血清濃度
급성림파세포백혈병%세포색소P4501A2%갑안접령%혈청농도
acute lymphoblastic leukemia%cytochrome P450 1 A2%methotrexate%serum concentration
目的:考察CYP1A2*1F( C-163A)基因多态性与急性淋巴细胞白血病( ALL)易感性及甲氨蝶呤( MTX)血清浓度的相关性。方法收集283名健康对照者和91例ALL患儿的外周血,提取基因组DNA。用聚合酶链反应-限制性片断长度多态性法(PCR-RFLP)检测CYP1A2*1F基因型,用荧光偏振免疫分析法(FPIA)测定24,42 h MTX血清浓度。结果健康对照人群和ALL患儿的CYP1A2*1F基因型与等位基因分布符合Hardy-Weinberg平衡,ALL患儿的A等位基因频率(43.41%)显著低于健康对照人群(64.66%)(P<0.01);A等位基因频率的优势比(OR)为0.42,显著降低ALL的发病风险(P<0.0001)。 CC、CA和AA基因型组ALL患儿的24,42 h MTX浓度与剂量比值( C/D ratio)差异无统计。结论 CYP1A2*1F可显著降低ALL的发病风险,A等位基因是ALL的保护等位基因,但与MTX血清浓度无显著相关关系。
目的:攷察CYP1A2*1F( C-163A)基因多態性與急性淋巴細胞白血病( ALL)易感性及甲氨蝶呤( MTX)血清濃度的相關性。方法收集283名健康對照者和91例ALL患兒的外週血,提取基因組DNA。用聚閤酶鏈反應-限製性片斷長度多態性法(PCR-RFLP)檢測CYP1A2*1F基因型,用熒光偏振免疫分析法(FPIA)測定24,42 h MTX血清濃度。結果健康對照人群和ALL患兒的CYP1A2*1F基因型與等位基因分佈符閤Hardy-Weinberg平衡,ALL患兒的A等位基因頻率(43.41%)顯著低于健康對照人群(64.66%)(P<0.01);A等位基因頻率的優勢比(OR)為0.42,顯著降低ALL的髮病風險(P<0.0001)。 CC、CA和AA基因型組ALL患兒的24,42 h MTX濃度與劑量比值( C/D ratio)差異無統計。結論 CYP1A2*1F可顯著降低ALL的髮病風險,A等位基因是ALL的保護等位基因,但與MTX血清濃度無顯著相關關繫。
목적:고찰CYP1A2*1F( C-163A)기인다태성여급성림파세포백혈병( ALL)역감성급갑안접령( MTX)혈청농도적상관성。방법수집283명건강대조자화91례ALL환인적외주혈,제취기인조DNA。용취합매련반응-한제성편단장도다태성법(PCR-RFLP)검측CYP1A2*1F기인형,용형광편진면역분석법(FPIA)측정24,42 h MTX혈청농도。결과건강대조인군화ALL환인적CYP1A2*1F기인형여등위기인분포부합Hardy-Weinberg평형,ALL환인적A등위기인빈솔(43.41%)현저저우건강대조인군(64.66%)(P<0.01);A등위기인빈솔적우세비(OR)위0.42,현저강저ALL적발병풍험(P<0.0001)。 CC、CA화AA기인형조ALL환인적24,42 h MTX농도여제량비치( C/D ratio)차이무통계。결론 CYP1A2*1F가현저강저ALL적발병풍험,A등위기인시ALL적보호등위기인,단여MTX혈청농도무현저상관관계。
Objective To investigate the association among CYP 1A2*1F (C-163A) polymorphisms and the risk to develop acute lymphoblas-tic leukemia ( ALL) and serum concentrations of methotrexate.Methods Peripheral blood samples were obtained from healthy subjects ( n=283 ) as control samples and children with ALL ( n =91 ) to extract genome DNA.Polymerase chain reaction -Restriction fragment length polymor-phism (PCR-RFLP) was used to detect the genotypes of CYP 1A2*1F polymorphisms.Fluorescence polarization immunoassay ( FPIA) was em-ployed to determine the serum concentrations of MTX at the 24 h and 42 h.Results The frequencies of genotypes and alleles at CYP 1A2*1F in healthy subjects and ALL children met Hardy -Weinberg equilibrium.The frequency of A allele in ALL children ( 43.41%) was significantly lower than that in healthy subjects (64.66%) (P<0.01).The odds ra-tio ( OR) of A allele was 0.42 , significantly reducing the risk to develop ALL ( P<0.0001 ).There were no significant differences in the dose -adjusted serum concentration (C/D ratio) of MTX at the 24, 42 h among CC, CA and AA genotype groups.Conclusion CYP1A2*1F signifi-cantly reduces the risk to develop ALL and A allele is a protective allele for ALL.However , there is no significant association between CYP 1 A2*1 F polymorphism and serum concentrations of MTX in ALL children.